GACAT3 and glioma: In glioma (Figure 2), GACAT3 targets miR-3127-5p to downregulate ELAVL1 expression, thereby significantly enhancing cell proliferation and colony formation of A172 cells, U251 cells, and xenograft tumors (Pan et al., 2019).